Abstract

BackgroundGout is associated with an increased risk of cardiovascular (CV) disease.ObjectivesWe aimed to investigate comparative CV risk among gout patients who initiated allopurinol versus febuxostat.MethodsUsing the 2002–2015 Korean National Health...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call